Clinical trials for childhood cancer drugs are critical, but parents don’t always understand what th
- OPACC
- Feb 25, 2016
- 1 min read
The dramatic improvements in survival for children with cancer depend on these clinical trials, and these trials depend on parents understanding the possible risks and benefits involved. But the parents of these young patients are usually unfamiliar with how these clinical trials work and are dealing with factors that make it difficult for them to give informed consent.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments